Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial

QR Code

Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial

Elizabeth Yeu,1 Steven Silverstein,2 Michel Guillon,3 Marc-Matthias Schulze,4 David Galarreta,5 Sruthi Srinivasan,6 Venkiteshwar Manoj6 1Virginia Eye Consultants, Norfolk, VA 23502, USA; 2Silverstein Eye Centers, Kansas City, MO 64133, USA; 3Ocular Technology Group International, London SW1E 6AU, UK...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yeu E, Silverstein S, Guillon M, Schulze MM, Galarreta D, Srinivasan S, Manoj V
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2020
Sujets:	aqueous deficient dry eye dry eye disease evaporative dry eye propylene glycol/hydroxypropyl guar-nanoemulsion ocular lubricant mixed dry eye Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/c30e0786e33c4d28a349b8a8f761a384
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
par: Silverstein S, et autres
Publié: (2020)

A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease
par: Jerkins G, et autres
Publié: (2020)

Making the diagnosis of Sjögren’s syndrome in patients with dry eye
par: Beckman KA, et autres
Publié: (2015)

Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study
par: Labetoulle M, et autres
Publié: (2018)

Efficacy of polyethylene glycol–propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease
par: Aguilar A, et autres
Publié: (2018)

Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
par: Ng A, et autres
Publié: (2018)

Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution
par: Favuzza E, et autres
Publié: (2020)

Comparing SPEED and OSDI Questionnaires in a Non-Clinical Sample
par: Hashmani N, et autres
Publié: (2021)

Assessment of tear-evaporation rate in thyroid-gland patients
par: Abusharaha A, et autres
Publié: (2019)

A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops
par: Srinivasan S, et autres
Publié: (2021)

Impact of Thermal Pulsation Treatment on Astigmatism Management and Outcomes in Meibomian Gland Dysfunction Patients Undergoing Cataract Surgery
par: Matossian C
Publié: (2020)

Adaptación cultural y validación del cuestionario Ocular Surface Disease Index en una población chilena
par: Traipe,Leonidas, et autres
Publié: (2020)

Ocular Surface Changes in Patients with Thyroid Eye Disease: An Observational Clinical Study
par: Allam IY, et autres
Publié: (2021)

Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A
par: Jariyakosol S, et autres
Publié: (2021)

Effect of Refresh Plus® preservative-free lubricant eyedrops on tear ferning patterns in dry eye and normal eye subjects
par: Alanazi SA, et autres
Publié: (2019)

Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains
par: Ebrahimiadib N, et autres
Publié: (2020)

Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
par: McDonald MB, et autres
Publié: (2018)

Patient-reported severity of dry eye and quality of life in diabetes
par: Yazdani-Ibn-Taz MK, et autres
Publié: (2019)

Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
par: Matossian C, et autres
Publié: (2021)

Ocular manifestations in patients with systemic sclerosis
par: Małgorzata Kozikowska, et autres
Publié: (2020)

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
par: Taylor M, et autres
Publié: (2019)

Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review
par: Atallah RT, et autres
Publié: (2019)

Investigating the potential benefits of a new artificial tear formulation combining two polymers
par: Simmons PA, et autres
Publié: (2017)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
par: Rhee MK, et autres
Publié: (2017)

Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery
par: Inoue Y, et autres
Publié: (2016)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
par: Deveney T, et autres
Publié: (2018)

High Prevalence of Abnormal Ocular Surface Tests in a Healthy Pediatric Population
par: Rojas-Carabali W, et autres
Publié: (2020)

Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City
par: Martinez JD, et autres
Publié: (2016)

Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
par: Pepose JS, et autres
Publié: (2019)

Exercise program improved subjective dry eye symptoms for office workers
par: Sano K, et autres
Publié: (2018)

Dynamics of tear fluid desiccation on a glass surface: a contribution to tear quality assessment
par: Traipe-Castro,Leonidas, et autres
Publié: (2014)

A new surgical approach for punctal occlusion using fibrous tissue from under the lacrimal caruncle
par: Yokoi N, et autres
Publié: (2018)

Dermatologists’ Knowledge and Attitudes Toward Dry Eye Disease, Refractive Surgery, and Contact Lenses When Prescribing Isotretinoin in Saudi Arabia
par: Basheikh A, et autres
Publié: (2020)

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
par: White DE, et autres
Publié: (2020)

Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study
par: Burillon C, et autres
Publié: (2018)

Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
par: White DE, et autres
Publié: (2020)

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease
par: McMullin D, et autres
Publié: (2021)

Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
par: Groß D, et autres
Publié: (2017)

Development of Lutein-Containing Eye Drops for the Treatment of Dry Eye Syndrome
par: Yi-Zhou Chen, et autres
Publié: (2021)

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
par: Amano S, et autres
Publié: (2017)